Context Therapeutics Inc. ownership update: an amendment to a Schedule 13G/A reports that Avidity-related entities and Michael Gregory hold sizeable shared voting and dispositive positions in the company. The disclosure lists 8,302,808 shares (representing 8.7%) for several Avidity entities and for Michael Gregory, and 7,364,795 shares (representing 7.7%) for Avidity Private Master Fund I.
The filing states these securities are directly owned by advisory clients of Avidity Partners Management LP and that the holdings are reported as shared voting and shared dispositive powers. Signatures and exhibits include a Joint Filing Agreement and Control Person identification; the filing is signed by Michael Gregory as managing member on 05/12/2026.
Positive
None.
Negative
None.
Insights
Large passive positions disclosed by Avidity across multiple entities.
Avidity-related entities are shown with 8,302,808 shares and 8.7% ownership in several listings, while Avidity Private Master Fund I holds 7,364,795 shares (7.7%). The filing characterizes these holdings as shared voting and shared dispositive power, indicating collective advisory control rather than sole control.
Cash-flow treatment and sale intentions are not stated in the excerpt; subsequent filings would disclose any changes in position. The reported percentages provide a clear snapshot of institutional concentration as of the amendment.
Joint filing and control-person exhibits standardize attribution across affiliated entities.
The schedule is filed as an amendment (Amendment No. 5) and includes a Joint Filing Agreement and Control Person Identification exhibit. Signatures show Michael Gregory acting as Managing Member across the listed entities, supporting the shared-power disclosures in Item 4.
Because the filing attributes holdings to advisory clients, the governance implication is that voting/dispositive power is exercised collectively through the adviser structure; any change in voting arrangements would require updated disclosures in future filings.
Key Figures
Amendment date / signature:05/12/2026Avidity shared holdings:8,302,808 sharesAvidity ownership percent:8.7%+2 more
5 metrics
Amendment date / signature05/12/2026Amendment No. 5 signature date by Michael Gregory
Avidity shared holdings8,302,808 sharesreported shared voting and dispositive power
Avidity ownership percent8.7%percent of class for several Avidity entities and Michael Gregory
Avidity Private Master Fund I holdings7,364,795 sharesreported shared voting and dispositive power
CUSIP21077P108Context Therapeutics common stock CUSIP
"Amendment No. 5 ) Context Therapeutics Inc. Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
What stake does Avidity report in Context Therapeutics (CNTX)?
Avidity-related entities report owning 8,302,808 shares, shown as 8.7% of common stock for several affiliates. A related fund, Avidity Private Master Fund I, reports 7,364,795 shares representing 7.7%.
Who is reported as the reporting person on the Schedule 13G/A for CNTX?
The filing lists Avidity Partners Management LP and affiliated entities plus Michael Gregory as reporting persons. Addresses and citizenship classifications for each entity are included in Item 2.
Does the filing show sole voting or dispositive power for Avidity in CNTX?
No. The filing shows 0 shares for sole voting and sole dispositive power and reports the positions under shared voting and shared dispositive power for the named entities.
Are the reported shares held directly or on behalf of clients?
The amendment states the securities are directly owned by advisory clients of Avidity Partners Management LP. It also notes that, other than Avidity Private Master Fund I, no single advisory client is identified as owning more than 5%.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 5)
Context Therapeutics Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
21077P108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Avidity Partners Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,302,808.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,302,808.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,302,808.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Avidity Partners Management (GP) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,302,808.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,302,808.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,302,808.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Avidity Capital Partners Fund (GP) LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,302,808.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,302,808.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,302,808.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Avidity Capital Partners (GP) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,302,808.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,302,808.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,302,808.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Avidity Private Master Fund I LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,364,795.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,364,795.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,364,795.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.7 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
21077P108
1
Names of Reporting Persons
Michael Gregory
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,302,808.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,302,808.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,302,808.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Context Therapeutics Inc.
(b)
Address of issuer's principal executive offices:
2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103
Item 2.
(a)
Name of person filing:
Avidity Partners Management LP
Avidity Partners Management (GP) LLC
Avidity Capital Partners Fund (GP) LP
Avidity Capital Partners (GP) LLC
Avidity Private Master Fund I LP
Michael Gregory
(b)
Address or principal business office or, if none, residence:
Avidity Partners Management LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Partners Management (GP) LLC
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Capital Partners Fund (GP) LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Capital Partners (GP) LLC
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Private Master Fund I LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Michael Gregory
c/o Avidity Partners Management LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
(c)
Citizenship:
Avidity Partners Management LP - Delaware
Avidity Partners Management (GP) LLC - Delaware
Avidity Capital Partners Fund (GP) LP - Delaware
Avidity Capital Partners (GP) LLC - Delaware
Avidity Private Master Fund I LP - Cayman Islands
Michael Gregory - United States
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
21077P108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Avidity Partners Management LP - 8,302,808
Avidity Partners Management (GP) LLC - 8,302,808
Avidity Capital Partners Fund (GP) LP - 8,302,808
Avidity Capital Partners (GP) LLC - 8,302,808
Avidity Private Master Fund I LP - 7,364,795
Michael Gregory - 8,302,808
(b)
Percent of class:
Avidity Partners Management LP - 8.7%
Avidity Partners Management (GP) LLC - 8.7%
Avidity Capital Partners Fund (GP) LP - 8.7%
Avidity Capital Partners (GP) LLC - 8.7%
Avidity Private Master Fund I LP - 7.7%
Michael Gregory - 8.7%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Avidity Partners Management LP - 0
Avidity Partners Management (GP) LLC - 0
Avidity Capital Partners Fund (GP) LP - 0
Avidity Capital Partners (GP) LLC - 0
Avidity Private Master Fund I LP - 0
Michael Gregory - 0
(ii) Shared power to vote or to direct the vote:
Avidity Partners Management LP - 8,302,808
Avidity Partners Management (GP) LLC - 8,302,808
Avidity Capital Partners Fund (GP) LP - 8,302,808
Avidity Capital Partners (GP) LLC - 8,302,808
Avidity Private Master Fund I LP - 7,364,795
Michael Gregory - 8,302,808
(iii) Sole power to dispose or to direct the disposition of:
Avidity Partners Management LP - 0
Avidity Partners Management (GP) LLC - 0
Avidity Capital Partners Fund (GP) LP - 0
Avidity Capital Partners (GP) LLC - 0
Avidity Private Master Fund I LP - 0
Michael Gregory - 0
(iv) Shared power to dispose or to direct the disposition of:
Avidity Partners Management LP - 8,302,808
Avidity Partners Management (GP) LLC - 8,302,808
Avidity Capital Partners Fund (GP) LP - 8,302,808
Avidity Capital Partners (GP) LLC - 8,302,808
Avidity Private Master Fund I LP - 7,364,795
Michael Gregory - 8,302,808
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G Amendment No. 5 are directly owned by advisory clients of Avidity Partners Management LP. None of those advisory clients, other than Avidity Private Master Fund I LP, may be deemed to beneficially own more than 5% of the Common Stock, par value $0.001 per share.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please see Exhibit B attached hereto.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Avidity Partners Management LP
Signature:
By: Avidity Partners Management (GP) LLC, its general partner, /s/ Michael Gregory
Name/Title:
Michael Gregory, Managing Member
Date:
05/12/2026
Avidity Partners Management (GP) LLC
Signature:
/s/ Michael Gregory
Name/Title:
Michael Gregory. Managing Member
Date:
05/12/2026
Avidity Capital Partners Fund (GP) LP
Signature:
By: Avidity Capital Partners (GP) LLC, its general partner, /s/ Michael Gregory
Name/Title:
Michael Gregory, Managing Member
Date:
05/12/2026
Avidity Capital Partners (GP) LLC
Signature:
/s/ Michael Gregory
Name/Title:
Michael Gregory, Managing Member
Date:
05/12/2026
Avidity Private Master Fund I LP
Signature:
By: Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, /s/ Michael Gregory
Name/Title:
Michael Gregory, Managing Member
Date:
05/12/2026
Michael Gregory
Signature:
/s/ Michael Gregory
Name/Title:
Michael Gregory
Date:
05/12/2026
Exhibit Information
[Exhibit A - Joint Filing Agreement]
[Exhibit B - Control Person Identification]
